Literature DB >> 34132802

Robustness and repeatability of GlycoWorks RapiFluor-MS IgG N-glycan profiling in a long-term high-throughput glycomic study.

Helena Deriš1, Ana Cindrić1, Matthew Lauber2, Tea Petrović1, Alicia Bielik3, Christopher H Taron3, Marleen van Wingerden2, Gordan Lauc1,4, Irena Trbojević-Akmačić1.   

Abstract

Protein glycosylation is the attachment of a carbohydrate moiety to a protein backbone affecting both structure and function of the protein. Abnormal glycosylation is associated with various diseases, and some of the changes in glycosylation are detectable even before symptom development. As such, glycans have emerged as compelling new biomarker candidates. A wide range of analytical methods exist for small-scale glycan analyses. However, there is a growing need for highly robust and reproducible high-throughput techniques that allow for large-scale glycoprofiling. Here, we describe the evaluation of robustness and repeatability of immunoglobulin G (IgG) N-glycan analysis using the GlycoWorks RapiFluor-MS N-Glycan Kit followed by hydrophilic interaction ultra-high-performance liquid chromatography (HILIC-UHPLC) from 335 technical replicates of human plasma randomly distributed across 67 96-well plates. The data was collected over a 5-month period using multiple UHPLC systems and chromatographic columns. Following relative IgG N-glycan quantification in acquired chromatograms, data analysis showed that the most abundant peaks that together made up for three-fourths of the detected IgG N-glycome all had coefficients of variation (CVs) lower than 2%. The highest CVs ranging from 16 to 29% accompanied low abundance glycan peaks with the individual relative peak area below 1% that together made up for <2% of the detected IgG N-glycome. These results show that the tested method is very robust and repeatable, making it suitable for the IgG N-glycan analysis of a large number of samples in a high-throughput manner over a longer period of time.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HILIC-UHPLC; N-glycosylation; RapiFluor-MS; high-throughput glycomics; immunoglobulin G

Mesh:

Substances:

Year:  2021        PMID: 34132802     DOI: 10.1093/glycob/cwab050

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  3 in total

1.  Immunoglobulin G glycome composition in transition from premenopause to postmenopause.

Authors:  Helena Deriš; Domagoj Kifer; Ana Cindrić; Tea Petrović; Ana Cvetko; Irena Trbojević-Akmačić; Ivana Kolčić; Ozren Polašek; Louise Newson; Tim Spector; Cristina Menni; Gordan Lauc
Journal:  iScience       Date:  2022-02-10

2.  Differences in Immunoglobulin G Glycosylation Between Influenza and COVID-19 Patients.

Authors:  Marina Kljaković-Gašpić Batinjan; Tea Petrović; Frano Vučković; Irzal Hadžibegović; Barbara Radovani; Ivana Jurin; Lovorka Đerek; Eva Huljev; Alemka Markotić; Ivica Lukšić; Irena Trbojević-Akmačić; Gordan Lauc; Ivan Gudelj; Rok Čivljak
Journal:  Engineering (Beijing)       Date:  2022-09-06       Impact factor: 12.834

3.  Effects of low-calorie and different weight-maintenance diets on IgG glycome composition.

Authors:  Helena Deriš; Petra Tominac; Frano Vučković; Nina Briški; Arne Astrup; Ellen E Blaak; Gordan Lauc; Ivan Gudelj
Journal:  Front Immunol       Date:  2022-09-21       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.